USA flag logo/image

An Official Website of the United States Government

LYMPHOTOXIN IS A LYMPHOKINE WHICH HAS POTENT ANTITUMOR ACTIVITY.

Award Information

Agency:
Department of Health and Human Services
Branch:
N/A
Award ID:
3029
Program Year/Program:
1985 / SBIR
Agency Tracking Number:
3029
Solicitation Year:
N/A
Solicitation Topic Code:
N/A
Solicitation Number:
N/A
Small Business Information
C-MOTION, INC.
C-MOTION, INC. 15821A CRABBS BRANCH WAY ROCKVILLE, MD 20855
View profile »
Woman-Owned: No
Minority-Owned: No
HUBZone-Owned: No
 
Phase 1
Fiscal Year: 1985
Title: LYMPHOTOXIN IS A LYMPHOKINE WHICH HAS POTENT ANTITUMOR ACTIVITY.
Agency: HHS
Contract: N/A
Award Amount: $50,000.00
 

Abstract:

LYMPHOTOXIN IS A LYMPHOKINE WHICH HAS POTENT ANTITUMOR ACTIVITY. IT IS A GLYCOPROTEIN WITH A MOLECULAR WEIGHT OF 25,000 DALTONS. DUE TO THE MINUTE AMOUNT PRODUCED BY LYMPHOCYTES, EVALUATION OF ITS PHARMACEUTICAL POTENTIAL REQUIRES THAT IT BE CLONED AND EXPRESSED IN A SUITABLE HOST. IN ORDER TO OBTAIN THE CORRECT GLYCOSYLATION PATTERN, WE PROPOSE TO EXPRESS IT IN MAMMALIAN CELLS. IN PHASE I, WE PLAN TO CLONE THE FULL-LENGTH LYMPHOTOXIN CDNA. PERIPHERAL BLOOD LYMPHOCYTES WILL BE USED FOR POLY(A) RNA ISOLATION FROM WHICH CDNA WILL BE SYNTHESIZED. THE VECTOR WE CHOOSE TO USE FOR ESTABLISHING A CDNA LIBRARY IS THE SINGLE-STRANDED PHAGE FL. THE CDNA LIBRARY WILL BE SCREENED WITH CHEMICALLY SYNTHESIZED OLIGONUCLEOTIDES. THE FULL-LENGTH CDNA WILL BE ASSEMBLED WITH OVERLAPPING RECOMBINANT CLONES IF NECESSARY. IT WILL ALSO BE SEQUENCED. IN ADDITION, THE ACTIVITY ASSAY FOR LYMPHOTOXIN WILL BE SET UP IN PHASE I. FOR PHASE II, WE PROPOSE TO WORK ON EXPRESSING THE CDNA IN MAMMALIAN CELL CULTURE AND MAXIMIZING THE LEVEL OF EXPRESSION.

Principal Investigator:

Jeni mao
PRINCIPAL INVESTIGATOR
6178619700

Business Contact:

Small Business Information at Submission:

Collaborative Research Inc
128 Spring Street Lexington, MA 02173

EIN/Tax ID: 522053087
DUNS: N/A
Number of Employees: N/A
Woman-Owned: No
Minority-Owned: No
HUBZone-Owned: No